EPISODE · Nov 14, 2019 · 28 MIN
Episode 31: T2DM treatment, T2DM with CVD or CKD, and pre-diabetes
from Primary Care Update · host Mark Ebell
A whole lotta diabetes goin' on: linagliptin ($780) vs glimepiride ($3) for T2DM (https://www.ncbi.nlm.nih.gov/pubmed/31536101); semaglutide in T2DM + vascular/CKD (https://www.ncbi.nlm.nih.gov/pubmed/31185157); and whether we should care about pre-diabetes (https://www.ncbi.nlm.nih.gov/pubmed/31076416).
What this episode covers
A whole lotta diabetes goin' on: linagliptin ($780) vs glimepiride ($3) for T2DM (https://www.ncbi.nlm.nih.gov/pubmed/31536101); semaglutide in T2DM + vascular/CKD (https://www.ncbi.nlm.nih.gov/pubmed/31185157); and whether we should care about pre-diabetes (https://www.ncbi.nlm.nih.gov/pubmed/31076416).
NOW PLAYING
Episode 31: T2DM treatment, T2DM with CVD or CKD, and pre-diabetes
No transcript for this episode yet
Similar Episodes
Jun 20, 2026 ·31m
Jun 20, 2026 ·24m
Jun 20, 2026 ·42m
Jun 20, 2026 ·26m
Jun 20, 2026 ·22m
Jun 20, 2026 ·37m